The role of oxidative DNA damage, DNA repair, GSTM1, SOD2 and OGG1 polymorphisms in individual susceptibility to Barrett's esophagus

Toxicology and Industrial Health

Volumn 26, Issue 2, 2010, Pages 67-79

  Kadioglu, Ela ^a   Sardas, Semra ^b   Ergun, Meltem ^a   Unal, Selahattin ^a   Karakaya, Ali Esat ^a  

^a GAZI UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Barrett's esophagus; comet assay; DNA repair; individual susceptibility; oxidative DNA damage

Indexed keywords

BIOLOGICAL MARKER; DNA GLYCOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; OXOGUANINE GLYCOSYLASE 1, HUMAN; SUPEROXIDE DISMUTASE; 8 OXOGUANINE DNA GLYCOSYLASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BARRETT ESOPHAGUS; CASE CONTROL STUDY; COMET ASSAY; DNA DAMAGE; DNA REPAIR; ENZYMOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY; ALLELE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN CELL; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING HABIT; WILD TYPE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COMET ASSAY; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; HYDROGEN PEROXIDE; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SUPEROXIDE DISMUTASE;

EID: 77951931830     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233709359278     Document Type: Article

References (47)

1. Akaa P., Mateucaa R., Buchetb JP, Thierensc H., and Kirsch-Volders M. (2004) Are genetic polymorphisms in OGG1, XRCC1 andXRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations? Mutation Research 556: 169-181.
2. Ambrosone CB, Freudenheim JL, Thompson PA, et al. (1999) Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Research 59: 602-606.
3. Au WW (2007) Usefulness of biomarkers in population studies: from exposure to susceptibility and to prediction of cancer. International Journal of Hygiene and Environmental Health 210: 239-246.
4. Beutler E., Duron O., and Kelly BM (1963) Improved method for the determination of blood glutathione. The Journal of Laboratory and Clinical Medicine. 61: 882-888.
5. Bonino JA, Sharma P. (2005) Barrett’s esophagus. Current Opinion in Gastroenterology 21: 461-465.
6. Cadet J., Bourdat AG, D’Ham C., et al. (2000) Oxidative base damage to DNA: specificity of base excision repair enzymes. Mutation Research 462: 121.
7. Casson AG, Zheng Z., Evans SC, Veugelers PJ, Porter GA, and Guernsey DL (2005) Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 26: 1536-1541.
8. Casson AG, Zheng Z., Porter GA, and Guernsey DL (2006) Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Cancer Detection and Prevention 30: 423-431.
9. Chao DL, Maley CC, Wu X., et al. (2006) Mutagen sensitivity and neoplastic progression in patients with Barrett’s esophagus: a prospective analysis. Cancer Epidemiology, Biomarkers & Prevention 15: 1935-1940.
10. Clemons NJ, McColl KE, and Fitzgerald RC (2007) Nitric oxide and acid induce double-strand DNA breaks in Barrett’s esophagus carcinogenesis via distinct mechanisms. Gastroenterology 133: 1198-1209.
11. Collins AR, Duthie SJ, and Dobson VL (1993) Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 14: 1733-1735.
12. Dvorak K., Fass R., Dekel R., et al. (2006) Esophageal acid exposure at pH ≤ 2 is more common in Barrett’s esophagus patients and is associated with oxidative stress. Diseases of the Esophagus 19: 366-372.
13. Dvorak K., Payne CM, Chavarria M., et al. (2007) Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus. Gut 56: 763-771.
14. Ellen L. Goode, Cornelia M. Ulrich, and John D. Potter (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiology, Biomarkers & Prevention 11: 1513-1530.
15. Farhadi A., Fields J., Banan A., and Keshavarzian A. (2002) Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett’s esophagus, and the latter’s progression toward esophageal cancer? The American Journal of Gastroenterology 97: 22-26.
16. Ferguson HR, Wild CP, Anderson LA, et al. (2008) No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett’s esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett’s adenocarcinoma relationship case-control study. Cancer Epidemiology, Biomarkers & Prevention 17: 736-739.
17. Fitzgerald RC (2005) Complex diseases in gastroenterology and hepatology: GERD, Barrett’s, and esophageal adenocarcinoma. Clinical Gastroenterology and Hepatology 3: 529-537.
18. Hermann B., Li Y., Ray MB, Wo JM, and Martin RCG, II (2005) Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus. Archives of Surgery 140: 1204-1209.
19. Ide H. (2000) DNA substrates containing defined oxidative base lesions and their application to study substrate specificities of base excision repair enzymes. Progress in Nucleic Acid Research and Molecular Biology 68: 207-221.
20. Jimenez P., Piazuelo E., Sanchez MT, Ortego J., Soteras F., and Lanas A. (2005) Free radicals and antioxidant systems in reflux esophagitis and Barrett’s esophagus. World Journal of Gastroenterology 11: 2697-2703.
21. Jolly AJ, Wild CP, and Hardie LJ (2004) Acid and bile salts induce DNA damage in human oesophageal cell lines. Mutagenesis 19: 319-324.
22. Kadioglu E., Sardas S., Aslan S., Isik E., and Karakaya AE (2004) Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer’s disease. Biomarkers 9: 203-209.
23. Kala Z., Dolina J., Marek F., and Holla LI (2007) Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett’s esophagus. Journal of Human Genetics 52: 527-534.
24. Kocabas NA, Sardas S., Cholerton S., Daly AK, Elhan AH, and Karakaya AE (2005) Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility. Cell Biochemistry and Function 23: 73-76.
25. Kohno T., Shinmura K., Tosaka M., et al. (1998) Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 16: 3219-3225.
26. Kollarova H., Machova L., Horakova D., Janoutova G., and Janout V. (2007) Epidemiology of esophageal cancer- an overview article. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 151: 17-28.
27. Lieshout EMM, Tiemessen DM, Witteman BJM, Jansen Jbmj, and Peters WHM (1999) Low glutathione and glutathione S-transferase levels in Barrett’s esophagus as compared to normal esophageal epithelium. Japanese Journal of Cancer Research 90: 81-85.
28. Murphy SJ, Hughes AE, Patterson CC, Anderson LA, Watson PRG, and Johnston BT (2007) A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett’s esophagus and esophageal adenocarcinoma. Carcinogenesis 28: 1323-1328.
29. Norppa H. (2003) Genetic susceptibility, biomarker responses, and cancer. Mutation Research 544: 339-348.
30. Oberg S., Wenner J., Johansson J., Walther B., and Willen R. (2005) Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Annals of Surgery 242: 49-54.
31. Olliver JR, Hardie LJ, Dexter S., Chalmers D., and Wild CP (2003) DNA damage levels are raised in Barrett’s oesophageal mucosa relative to the squamous epithelium of the oesophagus. Biomarkers 8: 509-521.
32. Olliver JR, Hardie LJ, Gong YY, et al. (2005) Risk factors, DNA damage, and disease progression in Barrett’s esophagus. Cancer Epidemiology, Biomarkers & Prevention 14: 620-625.
33. Olyaee M., Sontag S., Salman W., et al. (1995) Mucosal reactive oxygen species production in oesophagitis and Barrett’s oesophagus. Gut 37: 168-173.
34. Peters WH, Roelofs HM, Hectors MP, Nagengast FM, and Jansen JB (1993) Glutathione and glutathione S-transferases in Barrett’s epithelium. British Journal of Cancer 67: 1413-1417.
35. Raja S., Finkelstein SD, Baksh FK, et al. (2001) Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett’s esophagus. The Annals of Thoracic Surgery 72: 1130-1135.
36. Rantanen TK, Rasanen JV, Sihvo EIT, Ahotupa MO, Farkkila MA, and Salo JA (2006) The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study. The American Journal of Gastroenterology 101: 222-228.
37. Rebbeck TR (1997) Molecular epidemiology of the human glutathione s-transferase genotypes GSTM1 and GS7T1 in cancer susceptibility. Cancer Epidemiology, Biomarkers & Prevention 6: 733-743.
38. Salminen JT, Ramo OJ, Ahotupa MO, Farkkila MA, and Salo JA (2002) Increased DNA adducts in Barrett’s esophagus and reflux-related esophageal malignancies. Annals of Medicine 34: 565-570.
39. Sihvo EIT, Ruohtula T., Auvinen MI, Koivistoinen A., Harjula AL, and Salo JA (2003) Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus. The Journal of Thoracic and Cardiovascular Surgery 126: 1952-1957.
40. Sihvo EIT, Salminen JT, Rantanen TK, Ramo OJ, Ahotupa M., and Farkkila M. (2002) Oxidative stress has a role in malignant transformation in Barrett’s oesophagus. International Journal of Cancer 102: 551-555.
41. Toruner M., Soykan I., Ensar A., Kuzu I., Yurdaydın C., and Özden A. (2004) Barrett’s esophagus: prevalence and its relationship with dyspeptic symptoms. Journal of Gastroenterology and Hepatology 19: 535-540.
42. Wetscher GJ, Hinder RA, Bagchi D., et al. (1995) Reflux esophagitis in humans is mediated by oxygen-derived free radicals. American Journal of Surgery 170: 552-556.
43. Wetscher GJ, Hinder RA, Klingler P., Gadenstatter M., Perdikis G., and Hinder PR (1997) Reflux esophagitis in humans is a free radical event. Diseases of the Esophagus 10: 29-32.
44. Wild CP, Hardie LJ (2003) Reflux, Barrett’s oesophagus and adenocarcinoma: burning questions. Nature Reviews Cancer 3: 676-684.
45. Wild CP, Lawb GR, and Romanb E. (2002) Molecular epidemiology and cancer: promising areas for future research in the post-genomic era. Mutation Research 499: 3-12.
46. Xing D., Tan W., and Lin D. (2003) Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncology Reports 10: 1615-23.
47. Yılmaz N., Tuncer K., Tunçyürek M., Özütemiz Ö., and Bor S. (2006) The prevalence of Barrett’s esophagus and erosive esophagitis in a tertiary referral center in Turkey. The Turkish Journal of Gastroenterology 17: 79-83.